A comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia
- PMID: 29981266
- DOI: 10.1002/ajh.25204
A comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia
Comment in
- 
  
  A response by Strauss et al. to "a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia".Am J Hematol. 2018 Sep;93(9):E232-E233. doi: 10.1002/ajh.25200. Epub 2018 Aug 6. Am J Hematol. 2018. PMID: 30016554 No abstract available.
Comment on
- 
  
  Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial.Am J Hematol. 2018 May;93(5):683-690. doi: 10.1002/ajh.25060. Epub 2018 Feb 24. Am J Hematol. 2018. PMID: 29417614 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
 
        